口唇炎に対して処方した半夏瀉心湯に起因すると思われる間質性肺炎の1例

  • 鹿嶋 光司
    宮崎大学医学部感覚運動医学講座顎顔面口腔外科学分野
  • 松田 基弘
    Division of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital
  • 高森 晃一
    宮崎大学医学部感覚運動医学講座顎顔面口腔外科学分野
  • 井川 加織
    宮崎大学医学部感覚運動医学講座顎顔面口腔外科学分野
  • 吉岡 泉
    宮崎大学医学部感覚運動医学講座顎顔面口腔外科学分野
  • 迫田 隅男
    宮崎大学医学部感覚運動医学講座顎顔面口腔外科学分野

書誌事項

タイトル別名
  • A case of interstitial pneumonitis probably due to hangeshashinto prescribed for cheilitis
  • コウシンエン ニ タイシテ ショホウ シタ ハンゲシャシン ユ ニ キイン スル ト オモワレル カンシツセイ ハイエン ノ 1レイ

この論文をさがす

抄録

We report a case of drug-induced interstitial pneumonitis probably due to hangeshashinto prescribed for cheilitis. An 84-year-old woman came to our dental clinic complaining of erosion of the lower lip. She had a history of treatment for lumbar canal stenosis and had been prescribed limaprost alfadex for 3 years. Although she had been treated with steroidal ointment, vitamin B and cepharanthin by her dermatologist for 2 years, her symptom had not improved. Clinical examination revealed both erythematic and keratotic legions, and combined partially with desquamative erosion and crusting formation in the lower lip. A clinical diagnosis of cheilitis related to xerostomia was made, and we gave 15 mg of pilocarpine hydrochloride daily as well as steroidal ointment and several agents for oral rinse for 10 months with modest clinical efficacy. She then received 7.5 mg of Hangeshashinto daily for 3 weeks, which resulted in a complete response in the lip. However, she started to suffer dyspnea after 26 days from taking the medicine, and was referred to the regional general hospital. Since fine crackles were audible on auscultation and chest X-ray films showed widespread ground-glass shadows in both fields, drug-induced interstitial pneumonia was suspected. After cessation of the medicine and steroid pulse and successive oral steroidal therapies, her subjective symptoms improved considerably and the interstitial shadows observed on the chest X-ray films and chest CT were resolved.

収録刊行物

参考文献 (23)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ